Vivek Subbiah/X
Aug 9, 2025, 20:51
Vivek Subbiah: It Takes a Village to Bring Cutting-Edge Care to All Patients
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on X:
“Great to catch up with the amazing Lauren Meehan Machos! Thank you for visiting Nashville, your advocacy and for driving precision oncology forward in ALK, ROS1, and HER2+ cancer. It takes a village to bring cutting-edge care to all patients, and your impact echoes far.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 9, 2025, 19:54
Aug 9, 2025, 19:53
Aug 9, 2025, 19:37
Aug 9, 2025, 19:31
Aug 9, 2025, 19:17
Aug 9, 2025, 19:03